Please enter the email address you used to register, then we will send you a link to choose a new password
CMND: 60% | Clearmind Medicine shares are trading higher after the company signed an exclusive patent licensing agreement with Yissum Research Development Company.
HIMS: 18% | Hims & Hers Health share are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 and FY24 revenue guidance above estimates.
DAVE: 22% | Dave shares are trading higher after the company reported better-than-expected Q1 financial results and issued FY24 operating revenue.
Posted In: CMND DAVE HIMS